Mesar Plus

Olmesartan medoxomil and hydrochlorothiazide, the active ingredients in Mesar Plus, are an angiotensin II receptor blocker and a thiazide diuretic presented as an oral tablet for systemic use. They are indicated for the management of hypertension in adult patients, helping to lower elevated blood pressure and reduce cardiovascular risk.

GNH USA supplies Mesar Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable logistics for global distribution.

Mesar Plus combines an ARB and a thiazide diuretic to treat conditions within the hypertension disease family. - Hypertension: lowers systolic and diastolic blood pressure in patients with primary hypertension. - Essential hypertension: provides effective blood pressure control when monotherapy is insufficient. - Hypertension requiring combination therapy: offers a convenient single‑tablet regimen to improve adherence.

Mesar Plus may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Dizziness: sensation of light‑headedness, especially after standing. - Headache: mild to moderate pain in the head region. - Fatigue: feeling unusually tired or weak. - Increased urination: more frequent need to void. - Electrolyte imbalance: changes in potassium or sodium levels. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Severe hypotension: dangerously low blood pressure. - Acute kidney injury: sudden decline in renal function. - Hyperkalemia: elevated potassium concentration. - Angioedema: swelling of face, lips, or airway. - Pancreatitis: inflammation of the pancreas. - Hepatic dysfunction: abnormal liver enzyme elevations.

Before prescribing Mesar Plus, clinicians should consider several safety factors. - Renal function: assess baseline renal function and monitor periodically. - Electrolytes: monitor serum potassium and sodium levels during therapy. - Pregnancy: avoid use unless the potential benefit justifies the risk to the fetus. - Elderly: initiate at a lower dose and watch for orthostatic hypotension. - Concomitant NSAIDs: may attenuate the antihypertensive effect. - Store at ambient temperature: keep in the original pack, protect from moisture.

Mesar Plus can interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Aliskiren (in patients with diabetes): increased risk of renal impairment. - Potassium‑sparing diuretics: risk of hyperkalemia. - Lithium: heightened lithium toxicity.

Moderate Interactions (Monitor Closely): - Beta‑blockers: additive blood‑pressure‑lowering effect. - Calcium channel blockers: enhanced antihypertensive response.